Patents by Inventor Xiaohui He

Xiaohui He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7253164
    Abstract: This invention is directed to novel bicyclic compounds, to the uses of these compounds in various medicinal applications, including treating disorders amenable to treatment by peptidyl deformylase inhibitors such as treatment of bacterial infections, and to pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: August 7, 2007
    Assignee: IRM LLC
    Inventors: Valentina Molteni, Xiaohui He, Yun He, Andreas Kreusch, Juliet Nabakka, Kunyong Yang
  • Patent number: 7235662
    Abstract: Novel non-steroidal compounds are provided which are glucocorticoid receptor modulators which are useful in treating diseases requiring glucocorticoid receptor agonist or antagonist therapy such as obesity, diabetes, inflammatory and immune disorders, and have the structure where R1–R9, X, Y and Z are defined herein.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: June 26, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Sara Sabine Hadida-Ruah, Xiaohui He, Johnny Yasuo Nagasawa
  • Patent number: 7235656
    Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
    Type: Grant
    Filed: July 20, 2006
    Date of Patent: June 26, 2007
    Assignee: WiSys Technology Foundation, Inc.
    Inventors: James M. Cook, Qi Huang, Xiaohui He, Xioayan Li, Jianming Yu, Dongmei Han
  • Publication number: 20070054881
    Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
    Type: Application
    Filed: July 20, 2006
    Publication date: March 8, 2007
    Applicant: WISYS TECHNOLOGY FOUNDATION, INC.
    Inventors: James Cook, Qi Huang, Xiaohui He, Xiaoyan Li, Jianming Yu, Dongmei Han
  • Publication number: 20070049580
    Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
    Type: Application
    Filed: July 20, 2006
    Publication date: March 1, 2007
    Applicant: WiSys Technology Foundation, Inc.
    Inventors: James COOK, Qi Huang, Xiaohui He, Xioayan Li, Jianming Yu, Dongmei Han
  • Patent number: 7119196
    Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: October 10, 2006
    Assignee: Wisys Technology Foundation, Inc.
    Inventors: James M. Cook, Qi Huang, Xiaohui He, Xioayan Li, Jianming Yu, Dongmei Han, Snjezana Lelas, John F. McElroy
  • Publication number: 20050197326
    Abstract: This invention is directed to novel bicyclic compounds, to the uses of these compounds in various medicinal applications, including treating disorders amenable to treatment by peptidyl deformylase inhibitors such as treatment of bacterial infections, and to pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: July 30, 2004
    Publication date: September 8, 2005
    Inventors: Valentina Molteni, Xiaohui He, Yun He, Andreas Kreusch, Juliet Nabakka, Kunyong Yang
  • Publication number: 20040266758
    Abstract: Novel non-steroidal compounds are provided which are glucocorticoid receptor modulators which are useful in treating diseases requiring glucocorticoid receptor agonist or antagonist therapy such as obesity, diabetes, inflammatory and immune disorders, and have the structure 1
    Type: Application
    Filed: June 10, 2004
    Publication date: December 30, 2004
    Inventors: Sara Sabine Hadida-Ruah, Xiaohui He, Johnny Yasuo Nagasawa
  • Publication number: 20040177133
    Abstract: A computer readable medium, configuration server, and configuration system for receiving and processing a subscriber node address request is provided. A bridge service module provides a predetermined bridging criterion to a bridge extension module, the bridge extension module makes a bridging determination based on the bridging criterion and the subscriber node address request and provides a bridging message based on the subscriber node address request, when a result of the bridging determination indicates that the bridging message is to be provided. The configuration server may be a DHCP server in cable network environment, such that a cable modem receives an IP address and configuration data responsive to the subscriber node address request from a second DHCP server to which the bridging message is transmitted.
    Type: Application
    Filed: November 12, 2003
    Publication date: September 9, 2004
    Applicant: Next Generation Broadband
    Inventors: Bruce S. Harrison, Xiaohui He, Martin R. Hannes
  • Publication number: 20040082573
    Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
    Type: Application
    Filed: March 28, 2003
    Publication date: April 29, 2004
    Inventors: James M. Cook, Qi Huang, Xiaohui He, Xioayan Li, Jianming Yu, Dongmei Han, Snjezana Lelas, John F. McElroy